Published in Arterioscler Thromb Vasc Biol on September 01, 2000
Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am J Hum Genet (2001) 1.85
The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters. Br J Clin Pharmacol (2008) 0.90
Dietary cholesterol increases paraoxonase 1 enzyme activity. J Lipid Res (2012) 0.88
Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage. Eur J Clin Pharmacol (2004) 0.86
Pharmacogenetics of lipid diseases. Hum Genomics (2004) 0.85
Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization. Biochem J (2003) 0.84
The role of paraoxonase (PON) enzyme in the extent and severity of the coronary artery disease in type-2 diabetic patients. Heart Vessels (2007) 0.83
Serum paraoxonase 1 (PON1) measurement: an update. BMC Vet Res (2014) 0.81
Effect of cigarette smoking on paraoxonase 1 activity according to PON1 L55M and PON1 Q192R gene polymorphisms. Environ Health Prev Med (2011) 0.81
Simvastatin inhibits osteoclast differentiation by scavenging reactive oxygen species. Exp Mol Med (2011) 0.81
Paraoxonase: Its antiatherogenic role in chronic renal failure. Indian J Nephrol (2010) 0.80
Antioxidant effects of simvastatin in primary and secondary prevention of coronary heart disease. Eur J Clin Pharmacol (2006) 0.80
PPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways. PPAR Res (2012) 0.79
Simvastatin-induced changes in circulating oxidized low-density lipoprotein in different types of dyslipidemia. Heart Vessels (2010) 0.77
Brain Oxidative Stress During Experimental Sepsis Is Attenuated by Simvastatin Administration. Mol Neurobiol (2016) 0.77
Impact of Rosuvastatin Treatment on HDL-Induced PKC-βII and eNOS Phosphorylation in Endothelial Cells and Its Relation to Flow-Mediated Dilatation in Patients with Chronic Heart Failure. Cardiol Res Pract (2016) 0.75
Impact of antibacterial drugs on human serum paraoxonase-1 (hPON1) activity: an in vitro study. Asian Pac J Trop Biomed (2014) 0.75
A high throughput serum paraoxonase assay for discovery of small molecule modulators of PON1 activity. Curr Chem Genomics (2008) 0.75
Paraoxonase-1 and Simvastatin Treatment in Patients with Stable Coronary Artery Disease. Int J Vasc Med (2016) 0.75
Effects of APOA5 S19W polymorphism on growth, insulin sensitivity and lipoproteins in normoweight neonates. Eur J Pediatr (2011) 0.75
Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol (2001) 2.73
Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy terminus. EMBO J (1987) 2.67
Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke (1992) 2.65
Long-lasting sport practice and lone atrial fibrillation. Eur Heart J (2002) 2.26
[Estimation of the sample size in clinical and epidemiological investigations]. Med Clin (Barc) (1998) 2.18
Validation of the Minnesota Leisure Time Physical Activity Questionnaire in Spanish men. The MARATHOM Investigators. Am J Epidemiol (1994) 2.11
Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania. J Clin Microbiol (1999) 2.11
High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators. J Epidemiol Community Health (1998) 2.08
Ultralight metallic microlattices. Science (2011) 2.05
[Cefixime versus amoxicillin plus netilmicin in the treatment of community-acquired non-complicated acute pyelonephritis]. Med Clin (Barc) (1998) 1.95
Nucleotide sequence of a 13.9 kb segment of the 90 kb virulence plasmid of Salmonella typhimurium: the presence of fimbrial biosynthetic genes. Mol Microbiol (1993) 1.89
Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect (2008) 1.73
Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk. Eur J Vasc Endovasc Surg (2009) 1.72
Diarrhea in children under 5 years of age from Ifakara, Tanzania: a case-control study. J Clin Microbiol (2000) 1.72
Digestive anisakiasis: clinical manifestations and diagnosis according to localization. Rev Esp Enferm Dig (2002) 1.70
Timing for fever-related brain damage in acute ischemic stroke. Stroke (1998) 1.68
Prevalence of Shigella enterotoxins 1 and 2 among Shigella strains isolated from patients with traveler's diarrhea. J Clin Microbiol (1999) 1.63
Dietary patterns and associated lifestyles in preconception, pregnancy and postpartum. Eur J Clin Nutr (2006) 1.58
Validation of the Minnesota Leisure Time Physical Activity Questionnaire In Spanish Women. Investigators of the MARATDON Group. Med Sci Sports Exerc (2000) 1.57
Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates. Microbiol Immunol (1998) 1.53
Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA (2001) 1.53
High monetary costs of dietary patterns associated with lower body mass index: a population-based study. Int J Obes (Lond) (2006) 1.53
Triflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study. Neurology (2004) 1.52
Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis. J Hepatol (1994) 1.49
Dual phosphorylation and autophosphorylation in mitogen-activated protein (MAP) kinase activation. Biochem J (1993) 1.45
Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob Agents Chemother (2011) 1.43
[Management of myocardial infarction in Spain (1995-99). Data from the registry of the Ischaemic Heart Disease Working Group (RISCI) of the Spanish Society of Cardiology]. Rev Esp Cardiol (2001) 1.42
[Variability in the management and prognosis at short- and medium-term of myocardial infarct in Spain: the PRIAMHO study. Registration Project of Hospital Acute Myocardial Infarct]. Rev Esp Cardiol (1999) 1.42
[The prevalence of angina and cardiovascular risk factors in the different autonomous communities of Spain: the PANES Study. Prevalencia de Angina en España]. Rev Esp Cardiol (1999) 1.41
High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clin Microbiol Infect (2007) 1.40
Platelet glycoprotein IIb/IIIa blockers for percutaneous coronary revascularization, and unstable angina and non-ST-segment elevation myocardial infarction. Cochrane Database Syst Rev (2001) 1.40
Schinzel-Giedion syndrome: report of two sibs. Am J Med Genet (1995) 1.40
Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates. J Antimicrob Chemother (1999) 1.39
Enoxaparin as bridging anticoagulant treatment in cardiac surgery. Heart (2007) 1.38
Influence of the chemical environment on metolachlor conformations. J Agric Food Chem (1999) 1.38
Etiology of traveller's diarrhea in Spanish travellers to developing countries. Eur J Epidemiol (1993) 1.38
Comparison of acquisition of resistant microorganisms and infections in critically-ill patients with and without malignancies. Minerva Anestesiol (2013) 1.38
[Incidence of enteropathogens in patients with human immunodeficiency virus infection]. Med Clin (Barc) (1994) 1.38
Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study. Clin Microbiol Infect (2005) 1.36
Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces. J Hosp Infect (2011) 1.33
Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance. J Urol (2007) 1.33
Decreased permeability and enhanced proton-dependent active efflux in the development of resistance to quinolones in Morganella morganii. Int J Antimicrob Agents (2000) 1.33
Effect of malnutrition after acute stroke on clinical outcome. Stroke (1996) 1.29
Use of a three-day estimated food record, a 72-hour recall and a food-frequency questionnaire for dietary assessment in a Mediterranean Spanish population. Clin Nutr (2001) 1.28
CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii. Antimicrob Agents Chemother (2009) 1.27
Cholera outbreak in southern Tanzania: risk factors and patterns of transmission. Emerg Infect Dis (2001) 1.27
Response of oxidative stress biomarkers to a 16-week aerobic physical activity program, and to acute physical activity, in healthy young men and women. Atherosclerosis (2003) 1.26
Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections. Clin Infect Dis (2001) 1.26
Liver transplantation in patients with portal vein thrombosis. Liver Transpl (2001) 1.23
Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother (2013) 1.21
Bone remodelling in human immunodeficiency virus-1-infected patients. A histomorphometric study. Bone (1995) 1.17
Correlation of six methods for typing nosocomial isolates of Acinetobacter baumannii. J Med Microbiol (1995) 1.17
Rapid and accurate identification of genomic species from the Acinetobacter baumannii (Ab) group by MALDI-TOF MS. Clin Microbiol Infect (2011) 1.14
Acute myocardial infarction case fatality, incidence and mortality rates in a population registry in Gerona, Spain, 1990-1992. REGICOR Investigators. Int J Epidemiol (1998) 1.14
Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli by SOS-dependent or -independent pathways, respectively. Antimicrob Agents Chemother (2006) 1.14
Diamond-Blackfan syndrome: lymphocyte-mediated suppression of erythropoiesis. Science (1976) 1.13
Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli. Clin Microbiol Infect (2006) 1.11
Enteroaggregative Escherichia coli strains as a cause of traveler's diarrhea: a case-control study. J Infect Dis (1998) 1.11
A comparative study of two different methods of sample preparation for positive blood cultures for the rapid identification of bacteria using MALDI-TOF MS. Eur J Clin Microbiol Infect Dis (2011) 1.10
Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLs. Arterioscler Thromb Vasc Biol (2001) 1.08
Calculated low-density lipoprotein cholesterol should not be used for management of lipoprotein abnormalities in patients with diabetes mellitus. Diabetes Care (1993) 1.07
Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis. J Am Soc Nephrol (2001) 1.07
Integron-mediated antibiotic multiresistance in Acinetobacter baumannii clinical isolates from Spain. Clin Microbiol Infect (2003) 1.05
High-performance liquid chromatography method for the characterization of rhamnolipid mixtures produced by pseudomonas aeruginosa UG2 on corn oil. J Chromatogr A (1999) 1.04
Campylobacter jejuni as a cause of traveler's diarrhea: clinical features and antimicrobial susceptibility. J Travel Med (1998) 1.03
Increase in incidence of resistance to ampicillin, chloramphenicol and trimethoprim in clinical isolates of Salmonella serotype Typhimurium with investigation of molecular epidemiology and mechanisms of resistance. J Med Microbiol (1999) 1.03
Evolution of semen quality in North-eastern Spain: a study in 22,759 infertile men over a 36 year period. Hum Reprod (1999) 1.02
Improvement in survival after myocardial infarction between 1978-85 and 1986-88 in the REGICOR study. (Registre GIroní del COR) registry. Eur Heart J (1995) 1.02
Synchronus renal cell carcinoma and Bellini duct carcinoma: a case report on a rare coincidence. World J Urol (2000) 1.02
Late-onset anti-NMDA receptor encephalitis. Neurology (2013) 1.01
Intelligent telemonitoring of critical-care patients. IEEE Eng Med Biol Mag (1999) 1.01
Analysis of the mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of Salmonella serotype Typhimurium. J Med Microbiol (1997) 1.01
Community-acquired febrile urinary tract infection in diabetics could deserve a different management: a case-control study. J Intern Med (2003) 1.01
A clinical trial on the prevention of catheter-related sepsis using a new hub model. Ann Surg (1996) 1.01
Absence of viral rebound after treatment of HIV-infected patients with didanosine and hydroxycarbamide. Lancet (1997) 1.00
The region of the parE gene, homologous to the quinolone-resistant determining region of the gyrB gene, is not linked with the acquisition of quinolone resistance in Escherichia coli clinical isolates. J Antimicrob Chemother (1997) 1.00
Testicular self-examination: attitudes and practices among young men in Europe. Prev Med (1994) 0.99
Relationship of obesity distribution and peripheral arterial occlusive disease in elderly men. Int J Obes Relat Metab Disord (2001) 0.98
Anti-inflammatory effect of virgin olive oil in stable coronary disease patients: a randomized, crossover, controlled trial. Eur J Clin Nutr (2007) 0.98
Antimicrobial susceptibility and mechanisms of resistance to quinolones and beta-lactams in Acinetobacter genospecies 3. Antimicrob Agents Chemother (2004) 0.98
Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: a randomized, crossover, controlled, clinical trial. Atherosclerosis (2005) 0.98
In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii. Clin Microbiol Infect (2011) 0.98
First report of an OXA-23 carbapenemase-producing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain. Antimicrob Agents Chemother (2012) 0.97
Type 1 integrons in epidemiologically unrelated Acinetobacter baumannii isolates collected at Spanish hospitals. Antimicrob Agents Chemother (2004) 0.97
Quinolone resistance among Shigella spp. isolated from travellers returning from India. Clin Microbiol Infect (2007) 0.97
Relationship between diet and blood pressure in a representative Mediterranean population. Eur J Nutr (2002) 0.96
The development and validation of Spanish versions of the State and Trait Food Cravings Questionnaires. Behav Res Ther (2000) 0.96
Spread of NDM-2-producing Acinetobacter baumannii in the Middle East. J Antimicrob Chemother (2013) 0.96
The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae. Clin Microbiol Infect (2005) 0.96
Evaluation of two miniaturized systems, MicroScan W/A and BBL Crystal E/NF, for identification of clinical isolates of Aeromonas spp. J Clin Microbiol (2003) 0.95
Empirical solvation models in the context of conformational energy searches: application to bovine pancreatic trypsin inhibitor. Proteins (1992) 0.95
Two chromosomally located qnrB variants, qnrB6 and the new qnrB16, in Citrobacter spp. isolates causing bacteraemia. Clin Microbiol Infect (2009) 0.95
High frequency of mutations at codon 83 of the gyrA gene of quinolone-resistant clinical isolates of Escherichia coli. J Antimicrob Chemother (1995) 0.95